This introductory module presents fundamental aspects of cannabinoids and cannabinoid use. These include the endocannabinoid system, the cannabis plant and strains, public health and policy implications, and the results of the 2017 Canadian Cannabis Survey.

This module presents the perspectives of key stakeholders in the legalization of medical cannabis. These stakeholders include Health Canada, the Canadian Medical Association, the Canadian Nurses Association, the Canadian Pharmacist Association, and the patients.

This module presents the implications of the legalization of cannabis beyond the medical setting. Specifically, these videos demonstrate the implications of cannabis legalization on public health, youth education, the workplace, and advertising.

This module starts by discussing the use of medical cannabis in three special populations: pregnant women, older persons, and persons with Huntington’s disease. The module then presents a series of challenging and intriguing patient cases, and concludes with a presentation with regards to policy for Cannabinoids in the hospital and long-term care setting.

This module presents three distinct hot topics in the field of cannabinoids. These are: the role of the expanded endocannabinoid system in cardiometabolic risk, the potential opioid sparing effect of cannabinoids, and proposed metrics to evaluate the public health impact of legal non- medical cannabis in Canada.